Bone Biologics Corp Quarterly Common Stock, Shares, Issued from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Bone Biologics Corp quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q3 2024.
  • Bone Biologics Corp Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 2.1M shares, a 33.1% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.1M -1.04M -33.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.32M -1.82M -58% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 1.02M -15.7M -93.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 534K +470K +737% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 3.13M -7.22M -69.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 3.13M -7.22M -69.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 16.7M +6.35M +61.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 63.8K -10.3M -99.4% Dec 31, 2022 10-K 2024-02-21
Q3 2022 10.4M -1.92M -15.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 10.4M -20.3M -66.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 10.4M -20.3M -66.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 10.4M -1.92M -15.7% Dec 31, 2021 10-K 2023-03-30
Q3 2021 12.3M -18.4M -60% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 30.7M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 30.7M 0 0% Mar 31, 2021 10-Q 2021-05-21
Q4 2020 12.3M -18.4M -60% Dec 31, 2020 10-K 2022-03-15
Q3 2020 30.7M 0 0% Sep 30, 2020 10-Q 2021-04-15
Q2 2020 30.7M +617K +2.05% Jun 30, 2020 10-Q 2021-04-15
Q1 2020 30.7M +2.74M +9.82% Mar 31, 2020 10-Q 2021-04-15
Q4 2019 30.7M +4.23M +16% Dec 31, 2019 10-K 2021-04-15
Q3 2019 30.7M +22.2M +264% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 30.1M +25.6M +575% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 27.9M -16M -36.4% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 26.4M +22.1M +511% Dec 31, 2018 10-K 2020-03-30
Q3 2018 8.44M -30.6M -78.4% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 4.45M -34.4M -88.5% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 43.9M +5.1M +13.1% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 4.33M -34.5M -88.9% Dec 31, 2017 10-K 2019-03-29
Q3 2017 39.1M +249K +0.64% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 38.8M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 38.8M +746K +1.96% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 38.8M +6.62M +20.5% Dec 31, 2016 10-K 2018-04-02
Q3 2016 38.8M +7.67M +24.6% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 38.8M +9.59M +32.8% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 38.1M +13.8M +56.9% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 32.2M +7.94M +32.7% Dec 31, 2015 10-K 2017-03-30
Q3 2015 31.2M +13.2M +73.7% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 29.2M +24.1M +473% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 24.3M +19.3M +385% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 24.3M +13.3M +122% Dec 31, 2014 10-K 2016-03-28
Q3 2014 17.9M +12.9M +259% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 5.1M +98.7K +1.97% Jun 30, 2014 8-K 2014-09-25
Q1 2014 5M 0 0% Apr 30, 2014 10-Q 2014-06-23
Q4 2013 10.9M +5.93M +119% Dec 31, 2013 10-K 2015-03-31
Q3 2013 5M 0 0% Oct 31, 2013 10-Q 2014-09-15
Q2 2013 5M 0 0% Jul 31, 2013 10-Q 2013-09-11
Q1 2013 5M 0 0% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 5M 0 0% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 5M 0 0% Oct 31, 2012 10-K 2014-02-13
Q2 2012 5M 0 0% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 5M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 5M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 5M 0 0% Oct 31, 2011 10-K 2013-01-29
Q2 2011 5M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 5M Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.